Antibodies are essential molecules for diagnosis and treatment of diseases caused by
pathogens and their toxins. Antibodies were integrated in our medical repertoire against …

Monoclonal antibodies (mAbs) and their derivatives have achieved remarkable success as
medicine, targeting both diagnostic and therapeutic applications associated with …

With six approved products and more than 60 candidates in clinical testing, human
monoclonal antibody discovery by phage display is well established as a robust and reliable …

COVID-19 is a severe acute respiratory disease caused by SARS-CoV-2, a new recently
emerged sarbecovirus. This virus uses the human ACE2 enzyme as receptor for cell entry …

Since their first identification 50 years ago, marburgviruses have emerged several times,
with 83%–90% lethality in the largest outbreaks. Although no vaccines or therapeutics are …

Introduction: Monoclonal antibody-based therapies now represent the single-largest class of
molecules undergoing clinical investigation. Although a handful of different monoclonal …

Antibody phage display is regarded as a critical tool for the development of monoclonal
antibodies for infectious diseases. The different classes of antibody libraries are classified …

Viruses are widespread in the environment, and many of them are major pathogens of
serious plant, animal, and human diseases. The risk of pathogenicity, together with the …

Anthrax is an acute disease caused by the bacterium Bacillus anthracis, and is a potential
biowarfare/bioterrorist agent. Its pulmonary form, caused by inhalation of the spores, is …

Antibody phage display is a valuable in vitro technology to generate recombinant, sequence-
defined antibodies for research, diagnostics, and therapy. Up to now (autumn 2022), 14 …